口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状

doi:10.6040/j.issn.1673-3770.0.2020.428

摘要/Abstract

摘要： 鼻内镜鼻窦手术(ESS)已成为外科治疗慢性鼻窦炎伴鼻息肉(CRSwNP)的“金标准”,鼻内镜鼻窦手术围手术期管理对手术效果有重要影响。目前口服糖皮质激素因其抗炎和免疫抑制作用已作为ESS围术期辅助用药以增强手术效果,但在其剂量剂型及疗效等方面仍存在争议。回顾近年来研究口服糖皮质激素与CRSwNP围手术期疗效的相关文献,对口服糖皮质激素在围手术期的效果及治疗策略进行综述,以求提供更多的治疗选择和研究方向。

关键词: 鼻窦炎, 鼻息肉, 糖皮质激素, 鼻内镜手术

Abstract: Endoscopic sinus surgery (ESS) has become the “gold standard” for the surgical treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). The perioperative management of ESS has an important influence on the results of surgery. At present, oral glucocorticoids have been used as ESS perioperative adjuvant drugs to enhance the surgical effect due to their antiinflammatory and immunosuppressive effects. However, there are still controversies related to their dosage form and efficacy. This article reviews the recent studies on oral glucocorticoids and CRSwNPrelated literature on perioperative efficacy. The effects and treatment strategies of oral glucocorticoids during the perioperative period have been reviewed to provide more treatment options and research directions.

中图分类号:

R765

资昊坤,肖旭平,李云秋. 口服糖皮质激素在慢性鼻窦炎伴鼻息肉围手术期的应用现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 98-103.

ZI Haokun,XIAO Xuping, LI Yunqiu. Application status of oral corticosteroids during the perioperative period of chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 98-103.

参考文献

[1] Fokkens WJ, Lund VJ, Hopkins C, et al.European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(S29):1-464. doi: 10.4193/Rhin20.600.
[2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001. Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis(2018)[J]. Chin J Otorhinolaryngol Head Neck Surg, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001.
[3] 付清玲, 史剑波. 我国慢性鼻-鼻窦炎的流行病学特征及其伴随疾病和危险因素解析[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(5): 321-324. doi:10.13201/j.issn.1001-1781.2018.05.001. FU Qingling, SHI Jianbo. Epidemiology, occupational and environmental risk factors of chronic rhinosinusitis in China[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(5): 321-324. doi:10.13201/j.issn.1001-1781.2018.05.001.
[4] Albu S, Tomescu E. Small and large middle meatus antrostomies in the treatment of chronic maxillary sinusitis[J]. Otolaryngol Head Neck Surg, 2004, 131(4): 542-547. doi:10.1016/j.otohns.2004.02.045.
[5] Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy(POSE)scoring system[J]. Laryngoscope, 2007, 117(11 Pt 2 Suppl 115): 1-28. doi:10.1097/MLG.0b013e31814842f8.
[6] Pundir V, Pundir J, Lancaster G, et al. Role of corticosteroids in Functional Endoscopic Sinus Surgery: a systematic review and meta-analysis[J]. Rhinology, 2016, 54(1): 3-19. doi:10.4193/Rhin15.079.
[7] Shen KH, Wang YH, Hsu TW, et al. Differential effects of postoperative oral corticosteroid on eosinophilic vs. non-eosinophilic CRSwNP subtypes[J]. Am J Otolaryngol, 2019, 40(1): 22-29. doi:10.1016/j.amjoto.2018.09.005.
[8] 张罗, 强华, 王振刚, 等. 口服糖皮质激素治疗慢性鼻-鼻窦炎[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(2): 100-102. doi:10.3760/cma.j.issn.1673-0860.2013.02.006.
[9] Campbell RG. Risks and management of long-term corticosteroid use in chronic rhinosinusitis[J]. Curr Opin Otolaryngol Head Neck Surg, 2018, 26(1): 1-7. doi:10.1097/moo.0000000000000421.
[10] Richards RN. Side effects of short-term oral corticosteroids[J]. J Cutan Med Surg, 2008, 12(2): 77-81. doi:10.2310/7750.2008.07029.
[11] Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol Pract, 2016, 4(4): 565-572. doi:10.1016/j.jaip.2016.04.012.
[12] Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis[J]. Cochrane Database Syst Rev, 2016, 4: CD011991. doi:10.1002/14651858.CD011991.pub2.
[13] Karatzanis A, Chatzidakis A, Milioni A, et al. Contemporary use of corticosteroids in rhinology[J]. Curr Allergy Asthma Rep, 2017, 17(2): 11. doi:10.1007/s11882-017-0679-0.
[14] Younis RT, Ahmed J. Predicting revision sinus surgery in allergic fungal and eosinophilic mucin chronic rhinosinusitis[J]. Laryngoscope, 2017, 127(1): 59-63. doi:10.1002/lary.26248.
[15] Alobid I, Benítez P, Cardelús S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in Sino-nasal polyposis[J]. Laryngoscope, 2014, 124(1): 50-56. doi:10.1002/lary.24330.
[16] Byun SH, Min CY, Park IS, et al. Increased risk of chronic periodontitis in chronic rhinosinusitis patients: a longitudinal follow-up study using a national health-screening cohort[J]. J Clin Med,2020, 9(4): 1170. doi:10.3390/jcm9041170.
[17] Ramakrishnan VR. Ergonomics in endoscopic sinus surgery[J]. Curr Opin Otolaryngol Head Neck Surg, 2019, 27(1): 25-28. doi:10.1097/MOO.0000000000000504.
[18] Ecevit MC, Erdag TK, Dogan E, et al. Effect of steroids for nasal polyposis surgery: a placebo-controlled, randomized, double-blind study[J]. Laryngoscope, 2015, 125(9): 2041-2045. doi:10.1002/lary.25352.
[19] 张思远, 曹志伟. 口服糖皮质激素治疗慢性鼻-鼻窦炎伴鼻息肉[J]. 国际耳鼻咽喉头颈外科杂志, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012. ZHANG Siyuan, CAO Zhiwei. Oral glucocorticoids for chronic rhinosinusitis with nasal polyps[J]. Int J Dermatol Venereol, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012.
[20] de Borja Callejas F, Martínez-Antón A, Picado C, et al. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2015, 125(5):E158-67. doi: 10.1002/lary.25147.
[21] Hwang SH, Seo JH, Joo YH, et al. Does the preoperative administration of steroids reduce intraoperative bleeding during endoscopic surgery of nasal polyps?[J]. Otolaryngol Head Neck Surg, 2016, 155(6): 949-955. doi:10.1177/0194599816663455.
[22] Dautremont JF, Mechor B, Rudmik L. The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery[J]. Otolaryngol Head Neck Surg, 2014, 150(4): 689-695. doi:10.1177/0194599814521373.
[23] Wu X, Hong H, Zuo K, et al. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2016, 6(1): 75-81. doi:10.1002/alr.21625.
[24] 张宇, 宋西成. 慢性鼻窦炎伴鼻息肉与哮喘的相关性机制及治疗策略研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 49-52. doi:10.6040/j.issn.1673-3770.1.2018.033. ZHANG Yu, SONG Xicheng. Advances in interaction mechanisms and treatment strategy between chronic rhinosinusitis with nasal polyp and asthma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(1): 49-52. doi:10.6040/j.issn.1673-3770.1.2018.033.
[25] 陶丹丹, 董红军, 褚云锋, 等. 慢性鼻-鼻窦炎伴鼻息肉患者组织嗜酸性粒细胞与嗅觉功能障碍的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388. TAO Dandan, DONG Hongjun, CHU Yunfeng, et al. Correlation between eosinophils and olfactory dysfunction in patients with CRSwNP after nasal operation[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388.
[26] 娄鸿飞, 王成硕. 慢性鼻窦炎分型研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008. LOU Hongfei, WANG Chengshuo. Progress in classification of chronic sinusitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008.
[27] Akiyama K, Makihara S, Uraguchi K, et al. Impact of preoperative systemic corticosteroids on the histology and diagnosis of eosinophilic chronic rhinosinusitis[J]. Int Arch Allergy Immunol, 2019, 179(2): 81-88. doi:10.1159/000496437.
[28] Stevens WW, Ocampo CJ, Berdnikovs S, et al. Cytokines in chronic rhinosinusitis. role in eosinophilia and aspirin-exacerbated respiratory disease[J]. Am J Respir Crit Care Med, 2015, 192(6): 682-694. doi:10.1164/rccm.201412-2278OC.
[29] de Rosati D, Rosato C, Pagliuca G, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps[J]. Am J Otolaryngol, 2020, 41(1): 102286. doi:10.1016/j.amjoto.2019.102286.
[30] Ghogomu N, Kern R. Chronic rhinosinusitis: the rationale for current treatments[J]. Expert Rev Clin Immunol, 2017, 13(3): 259-270. doi:10.1080/1744666X.2016.1220833.
[31] 戴飞, 魏瑾瑾, 汤欣玥, 等. 2-APB体外抑制嗜中性粒细胞型鼻息肉中的炎症反应[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 97-100. doi:10.6040/j.issn.1673-3770.0.2019.413. DAI Fei, WEI Jinjin, TANG Xinyue, et al. 2-aminoethoxydiphenyl borate inhibits inflammatory reactions of neutrophilic nasal polyps in vitro[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(4): 97-100. doi:10.6040/j.issn.1673-3770.0.2019.413.
[32] Wen WP, Liu WL, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy[J]. J Allergy Clin Immunol, 2012, 129(6): 1522-1528.e5. doi:10.1016/j.jaci.2012.01.079.
[33] Wang W, Gao Y, Zhu Z, et al. Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years[J]. Int Forum Allergy Rhinol, 2019, 9(2): 149-157. doi:10.1002/alr.22234.
[34] Wang XD, Zhang N, Bo MY, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5): 1344-1353. doi:10.1016/j.jaci.2016.05.041.
[35] Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis[J]. Allergol Int, 2019,68(4):403-412. doi: 10.1016/j.alit.2019.07.002.
[36] Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma[J]. Allergy, 2019, 74(12): 2312-2319. doi:10.1111/all.13875.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed